<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
    <channel>
        <title>PR.com Press Releases: New Life Scientific, Inc. News</title>
        <description>Latest news releases from PR.com for New Life Scientific, Inc.</description>
        <link>http://www.pr.com/press-releases</link>
        <lastBuildDate>Tue, 07 Oct 2008 19:43:39 -0500</lastBuildDate>
        <image>
            <url>http://www.pr.com/images/logo_white.jpg</url>
            <title>Press Releases from PR.com</title>
            <link>http://www.pr.com/</link>
            <width>68</width>
            <height>69</height>
            <description>PR.com provides Free Press Release Distribution, &amp; is a unique Directory of Businesses, Products, Services, &amp; Jobs - in all industries.  Find Full Company Profiles.</description>
        </image>
        <copyright>© 2008 PR Worldwide, Inc.</copyright>
        <ttl>60</ttl>
        <item>
            <title>NWLS Transfers Marketing License Relating to Innovative Topical Drug Delivery to Atlan International</title>
            <link>http://www.pr.com/press-release/31145</link>
            <description>New Life Scientific, Inc. (OTCBB: NWLS), a company which specializes in the development of new biotechnology products and pharmaceuticals, announced today that it has transferred marketing rights to Atlan International(OTC: ATLI) of license agreement for two platform technologies (patent pending) that will allow formulation of topical drugs for various applications. NWLS is major shareholder of ATLI, both companies shall [PR.com - February 27, 2007]</description>
            <author>New Life Scientific, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/31145</guid>
        </item>
        <item>
            <title>PharmaTrials Announces Expansion Plan into Asia</title>
            <link>http://www.pr.com/press-release/28681</link>
            <description>Pharma Trials International, Inc. a subsidiary of New Life Scientific, Inc. (OTCBB: NWLS), specializes in providing clinical trial services, market research, and services to enable pharmaceutical, biotech and medical device companies worldwide to conduct research and to obtain regulatory approval of their products. PharmaTrials International, Inc. (PTI) today announced plans to expand its presence into Asia, and is [PR.com - February 01, 2007]</description>
            <author>New Life Scientific, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/28681</guid>
        </item>
        <item>
            <title>New Life Scientific Moves into New Headquarters</title>
            <link>http://www.pr.com/press-release/16912</link>
            <description>New Life Scientific, Inc (NWLS)  a developmental biotech company whose core focus is to develop and commercialize novel biotech/pharmaceutical products including vaccines and stem cell based treatment modalities and to expand through our own research, collaborations, acquisitions and in-licensing, announced today that they have moved into their new corporate headquarters in Princeton, NJ.

Wieslaw Bochenek New [PR.com - September 01, 2006]</description>
            <author>New Life Scientific, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/16912</guid>
        </item>
        <item>
            <title>New Life Scientific Enters New Phase</title>
            <link>http://www.pr.com/press-release/9079</link>
            <description>New Life Scientific, Inc (NWLS), today announced that at the special meeting of the Board of Directors a decision was made to re-evaluate its current progress and review its future options being considered include reviewing opportunities to acquire, license, and/or joint venture various medical, pharmaceutical, biotech products and medical devises. Management is also evaluating the status of current subsidiaries and [PR.com - April 11, 2006]</description>
            <author>New Life Scientific, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/9079</guid>
        </item>
        <item>
            <title>New Life Scientific, Inc. and Telomolecular Corp Announce Strategic Alliance Agreement</title>
            <link>http://www.pr.com/press-release/4604</link>
            <description>New Life Scientific, Inc. (OTCBB:NWLF - News) and Telomolecular Corp, have announced a strategic alliance to develop products that treat aging and age-related disease.

New Life Scientific, Inc a company engaged in developing pharmaceutical products as well as managing PharmaTrials International (PTI), a wholly owned subsidiary of NWLF which operates a Contract Research Organization (CRO) in Kiev, Ukraine. Telomolecular [PR.com - December 05, 2005]</description>
            <author>New Life Scientific, Inc.</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/4604</guid>
        </item>
    </channel>
</rss>
